Kinetics of the QuantiFERON^®-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease

References

• Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007;131: 1898–906.
   PubMed Web of Science ®Google Scholar
• Pai M, Zwerling A, Menzies D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177–84.
   PubMed Web of Science ®Google Scholar
• Dheda K, Smit RZ, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009;15:188–200.
   PubMedGoogle Scholar
• Soborg B, Andersen AB, Larsen HK, Weldingh K, Andersen P, Kofoed K, . Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis 2007;39:554–9.
   PubMed Web of Science ®Google Scholar
• Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, . Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 2008;46:474–5; author reply 475.
   PubMedGoogle Scholar
• Raby E, Moyo M, Devendra A, Banda J, De Haas P, Ayles H, . The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 2008;3:e2489.
   PubMedGoogle Scholar
• Aabye MG, Ravn P, PrayGod G, Jeremiah K, Mugomela A, Jepsen M, . The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009;4:e4220.
   Google Scholar
• Domínguez J, De Souza-Galvão M, Ruiz-Manzano J, Latorre I, Prat C, Lacoma A, . T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after anti-tuberculosis treatment. Diagn Microbiol Infect Dis 2009;63:43–51.
   PubMed Web of Science ®Google Scholar
• Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. . Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect 2009;58:197–204.
   PubMedGoogle Scholar
• Kobashi Y, Sugiu T, Ohue Y, Mouri K, Obase Y, Miyashita N, . Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease. Intern Med 2008;47:1957–61.
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008;12:1146–52.
   PubMedGoogle Scholar
• Adetifa IM, Lugos MD, Hammond A, Jeffries D, Donkor S, Adegbola RA, . Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis 2007;7:122.
   PubMedGoogle Scholar
• Wejse C, Gustafson P, Nielsen J, Gomes VF, Aaby P, Andersen PL, . TBscore: signs and symptoms from tuberculosis patientsin a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis 2007;40: 2111–20.
   Google Scholar
• Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 2008;15:425–32.
   PubMedGoogle Scholar
• Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, Kruger C, . Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol 2009;16:1170–5.
   PubMed Web of Science ®Google Scholar
• Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 2008;133: 1415–20.
   PubMed Web of Science ®Google Scholar
• Igari H, Watanabe A, Sato T. Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis 2007;11:788–91.
   PubMed Web of Science ®Google Scholar
• Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, . Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J 2007;29:1212–6.
   PubMed Web of Science ®Google Scholar
• Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, . Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174:349–55.
   PubMed Web of Science ®Google Scholar
• Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, . Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2006;175:514–20.
   PubMedGoogle Scholar
• Van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, . Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009;180:49–58.
   PubMedGoogle Scholar